spacer
home > pmps > autumn 2017 > more than boxes and bottles
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

More than Boxes and Bottles

Although it is a common poison of choice in murder mysteries, arsenic was used as a cure for disease in the late Victorian era. From the questionable rituals of the Tudor period to lobotomies of the 1900s, throughout history we have seen too many crazy medical practices. Thankfully, today’s pharmaceutical industry is far more sophisticated and heavily regulated. However, it is not just medicine itself that has advanced, so has the pharma packaging designed to protect and store these products.

The pharma packaging market is currently experiencing an annual growth rate of around 5% a year and is now estimated to be worth over £15 billion. Nevertheless, as community and hospital pharmacies are under pressure to meet budgetary expectations, packaging selection can often fall to the bottom of the priority list.

Like other packaged goods, pharmaceuticals need reliable and cost-effective packaging solutions. However, the industry has more complex requirements for packaging than average consumer products. Due to the sensitive nature of the industry, pharmacists must pay careful attention when choosing their packaging options.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Oliver Pittock is the managing director of pharma packaging specialist, Valley Northern. Oliver built his commitment to the healthcare and pharmacy supply business through seeing his father’s business grow throughout the 1970s. Moving to the Midlands in 1993, Oliver set up Valley Northern, which became a limited company in 2014.
spacer
Oliver Pittock
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

rfxcel Covers the Cost of EMVO Onboarding Fees

May 23, 2018 - San Ramon, CA – rfxcel Corporation, a technically certified Gateway Provider for the European Medicines Verification Organisation (EMVO) announced today that it will pay the cost of statutory fees payable to EMVO* for all manufacturers (Marketing Authorisation Holders, MAHs) which select rfxcel as their Gateway Provider before June 15th 2018.
More info >>

White Papers

Changing Structural Landscape for Comparator Drug Supply

ADAllen Pharma

TransCelerate Biopharma is focused on advancing innovation in R&D, identifying and solving common R&D challenges and further improving patient safety, with the goal of delivering more high quality medicines to patients. In 2013, they announced its Clinical Trial Comparator Network initiative to show a mutual commitment to offer secure and rapid supply of comparator drug products. The aim of this article is to unpack the section on 'Comparator Drugs' and analyse the rationale for attempting to achieve their objectives.
More info >>

 
Industry Events

Outsourcing in Clinical Trials Medical Device USA 2018

11-12 July 2018, Minneapolis, Minnesota

6th Outsourcing in Clinical Trials conference is the only clinical outsourcing platform for medical device companies within Medical Alley this year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement